1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. KYMERA THERAPEUTICS INC
Kymera Therapeutics Inc XNAS: KYMR

Kymera Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Momentum Trap
about

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' li...

Read More
44.54 -0.36 (-0.80%)
129.12% Gain from 52W Low
544.1K
XNAS Volume

XNAS 15 Jul, 2025 12:18 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
11.1 / 100
Valuation Score
Expensive Valuation
8.3 / 100
Momentum Score
Technically Neutral
53.2 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
60
1Yr Price target upside is 35%
19 analysts

9

S

9

W

1

O

2

T

SWOT Analysis

Kymera Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..